ARCHIVES

FDA To Reorganize Oncology Office Into Four Divisions By Disease Type

This article is from The Cancer Letter archive.

Vol. 36 No. 30 | August 6, 2010

Download PDF Visit The Full Archive

Related Articles

Cancer Genetics: risk from Three BRCA Mutations Lower Than Expected, NCI Finds

May 23, 1997

Hatch Committee Clears Bill Blocking OMB Micromanagement

August 15, 1986

“Imaginary Treatments,” “Wonderful Cures”

June 6, 1997

Regulatory Agencies: Groups Petition FDA To Ease Silicone Gel Implant Restrictions

September 27, 1996

NCI Splits Prevention and control Division; Rimer to Direct Division Of Cancer Conrol

July 25, 1997

Funding opportunities listed.

October 8, 2004